Free Trial
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free GENI Stock Alerts

GENinCode (GENI) Competitors

GENinCode logo
GBX 0.94 -0.01 (-1.37%)
As of 06/12/2026 11:32 AM Eastern
Compare

GENI vs. EDR, DIS, AMC, LION, and SPHR

Should you buy GENinCode stock or one of its competitors? MarketBeat compares GENinCode with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GENinCode include Egdon Resources (EDR), Distil (DIS), Amur Minerals (AMC), Lionsgold (LION), and Sphere Medical (SPHR). These companies are all part of the "entertainment" industry.

How does GENinCode compare to Egdon Resources?

Egdon Resources (LON:EDR) and GENinCode (LON:GENI) are both small-cap entertainment companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

Egdon Resources has a beta of -0.25, suggesting that its stock price is 125% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.588, suggesting that its stock price is 41% less volatile than the broader market.

18.6% of Egdon Resources shares are owned by institutional investors. Comparatively, 4.5% of GENinCode shares are owned by institutional investors. 63.8% of Egdon Resources shares are owned by insiders. Comparatively, 8.7% of GENinCode shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Egdon Resources and Egdon Resources both had 1 articles in the media. Egdon Resources' average media sentiment score of 0.00 beat GENinCode's score of -0.95 indicating that Egdon Resources is being referred to more favorably in the media.

Company Overall Sentiment
Egdon Resources Neutral
GENinCode Negative

Egdon Resources has higher revenue and earnings than GENinCode.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Egdon Resources£8.08M0.00£2.51MN/AN/A
GENinCode£2.91M2.33-£6.10M-£2.35N/A

Egdon Resources has a net margin of 31.06% compared to GENinCode's net margin of -185.47%. Egdon Resources' return on equity of 8.26% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
Egdon Resources31.06% 8.26% 4.22%
GENinCode -185.47%-409.40%-63.99%

Summary

Egdon Resources beats GENinCode on 9 of the 10 factors compared between the two stocks.

How does GENinCode compare to Distil?

Distil (LON:DIS) and GENinCode (LON:GENI) are both small-cap entertainment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Distil has higher earnings, but lower revenue than GENinCode. Distil is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Distil£963K1.10-£2.19M-£0.08N/A
GENinCode£2.91M2.33-£6.10M-£2.35N/A

In the previous week, GENinCode had 1 more articles in the media than Distil. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Distil. Distil's average media sentiment score of 0.00 beat GENinCode's score of -0.95 indicating that Distil is being referred to more favorably in the media.

Company Overall Sentiment
Distil Neutral
GENinCode Negative

Distil has a beta of 0.873, meaning that its share price is 13% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.588, meaning that its share price is 41% less volatile than the broader market.

Distil has a net margin of -126.58% compared to GENinCode's net margin of -185.47%. Distil's return on equity of -21.81% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
Distil-126.58% -21.81% -7.50%
GENinCode -185.47%-409.40%-63.99%

0.0% of Distil shares are owned by institutional investors. Comparatively, 4.5% of GENinCode shares are owned by institutional investors. 22.8% of Distil shares are owned by insiders. Comparatively, 8.7% of GENinCode shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Distil beats GENinCode on 8 of the 13 factors compared between the two stocks.

How does GENinCode compare to Amur Minerals?

GENinCode (LON:GENI) and Amur Minerals (LON:AMC) are both small-cap entertainment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

In the previous week, GENinCode had 1 more articles in the media than Amur Minerals. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Amur Minerals. Amur Minerals' average media sentiment score of 0.00 beat GENinCode's score of -0.95 indicating that Amur Minerals is being referred to more favorably in the news media.

Company Overall Sentiment
GENinCode Negative
Amur Minerals Neutral

Amur Minerals has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Amur Minerals' return on equity of -14.97% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
GENinCode-185.47% -409.40% -63.99%
Amur Minerals N/A -14.97%-7.77%

Amur Minerals has lower revenue, but higher earnings than GENinCode.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GENinCode£2.91M2.33-£6.10M-£2.35N/A
Amur MineralsN/AN/A-£2.39MN/AN/A

4.5% of GENinCode shares are owned by institutional investors. 8.7% of GENinCode shares are owned by company insiders. Comparatively, 1.5% of Amur Minerals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

GENinCode has a beta of 0.588, indicating that its stock price is 41% less volatile than the broader market. Comparatively, Amur Minerals has a beta of 0.3, indicating that its stock price is 70% less volatile than the broader market.

Summary

GENinCode beats Amur Minerals on 6 of the 11 factors compared between the two stocks.

How does GENinCode compare to Lionsgold?

Lionsgold (LON:LION) and GENinCode (LON:GENI) are both entertainment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

In the previous week, GENinCode had 1 more articles in the media than Lionsgold. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Lionsgold. Lionsgold's average media sentiment score of 0.00 beat GENinCode's score of -0.95 indicating that Lionsgold is being referred to more favorably in the media.

Company Overall Sentiment
Lionsgold Neutral
GENinCode Negative

4.5% of GENinCode shares are owned by institutional investors. 8.7% of GENinCode shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Lionsgold has higher earnings, but lower revenue than GENinCode.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LionsgoldN/AN/AN/AN/AN/A
GENinCode£2.91M2.33-£6.10M-£2.35N/A

Lionsgold has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Lionsgold's return on equity of 0.00% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
LionsgoldN/A N/A N/A
GENinCode -185.47%-409.40%-63.99%

Summary

Lionsgold and GENinCode tied by winning 4 of the 8 factors compared between the two stocks.

How does GENinCode compare to Sphere Medical?

Sphere Medical (LON:SPHR) and GENinCode (LON:GENI) are both entertainment companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

In the previous week, GENinCode had 1 more articles in the media than Sphere Medical. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Sphere Medical. Sphere Medical's average media sentiment score of 0.00 beat GENinCode's score of -0.95 indicating that Sphere Medical is being referred to more favorably in the media.

Company Overall Sentiment
Sphere Medical Neutral
GENinCode Negative

4.5% of GENinCode shares are held by institutional investors. 8.7% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Sphere Medical has higher earnings, but lower revenue than GENinCode.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sphere MedicalN/AN/AN/AN/AN/A
GENinCode£2.91M2.33-£6.10M-£2.35N/A

Sphere Medical has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Sphere Medical's return on equity of 0.00% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
Sphere MedicalN/A N/A N/A
GENinCode -185.47%-409.40%-63.99%

Summary

Sphere Medical and GENinCode tied by winning 4 of the 8 factors compared between the two stocks.

Get GENinCode News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GENI vs. The Competition

Export
MetricGENinCodeDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£7.15M£63.35M£6.74B£3.00B
Dividend YieldN/A3.31%2.67%6.18%
P/E Ratio-0.4072.7524.19366.78
Price / Sales2.33619.89511.2086,623.71
Price / Cash0.8311.4243.5427.87
Price / Book0.583.5210.657.85
Net Income-£6.10M£334.07B£3.57B£5.89B
7 Day Performance-19.91%-1.51%0.83%-0.06%
1 Month Performance-10.76%-7.14%0.09%1.39%
1 Year Performance-59.96%3.64%25.18%75.30%

GENinCode Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GENI
GENinCode
N/AGBX 0.94
-1.4%		N/A-59.3%£7.15M£2.91MN/A2,300
EDR
Egdon Resources
N/AN/AN/AN/A£24.88M£8.08M220.0011,000
DIS
Distil
N/AGBX 0.07
+37.3%		N/A-77.2%£1.42M£963KN/A220,000
AMC
Amur Minerals
N/AN/AN/AN/A£1.25MN/AN/A33,700
LION
Lionsgold
N/AN/AN/AN/A£0.00N/AN/A2,021

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:GENI) was last updated on 6/13/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel